CE mark for Cryolife’s hybrid stentApril 4, 2020
CryoLife has received CE Mark for the Evita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease.
The aortic arch disease includes both aortic aneurysms and aortic dissections, which occur suddenly and usually without warning.
Many patients with either an aneurysm or dissection in the aortic arch also present with a dissected or aneurysmal descending thoracic aorta. Often these two conditions are repaired in a two-stage procedure – one to repair the arch and the next to repair the descending thoracic aorta, the company said.
The hybrid stent graft technologies, which include the E-vita Open NEO and the E-vita Open Plus, enable a one-stage procedure treatment of this condition by combining the surgical arch repair and the endovascular descending thoracic repair.